Intracavitary «in vivo» dosimetry at the high dose rate brachytherapy in oncogynecology

«Radiation and Risk», 2022, vol. 31, No. 4, pp.119-131

DOI: 10.21870/0131-3878-2022-31-4-119-131

Authors

Bogacheva V.V. – Sen. Researcher, C. Sc., Biol. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: (484) 399-70-02; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Stepanenko V.F. – Head of Lab., D. Sc., Biol., Prof.
Krikunova L.I. – Head of Dep., MD, Prof.
Petukhov A.D. – Researcher, C. Sc., Biol
Kulieva G.Z. – Jun. Researcher
Kolyzhenkov T.V. – Lead. Researcher, C. Sc., Biol.
Korotkov V.A. – Head of Dep., C. Sc., Med. A. Tsyb MRRC.
Zharova E.P. – Scien. Secretary
Shegay P.V. – Deputy Gen. Director, C. Sc., Med. NMRRC.
Ivanov S.A. – Director of A. Tsyb MRRC, Corr. Member of RAS, MD, Prof. of PFUR Dep.
Kaprin A.D. – General Director of NMRRC, Head of PFUR Dep., Academician of RAS, MD, Prof.
¹ A. Tsyb MRRC, Obninsk
² NMRRC, Obninsk
³ Peoples' Friendship University of Russia, Moscow

Abstract

The technology for construction and application of flexible dosimetric assemblies with LiF:Mg,Ti microcrystals (sizes of about 0.1 mm) for off-line measurements of the spatial distribution of the absorbed dose inside organs at risk (rectum, urethra, vagina) at high dose rate brachytherapy in oncoginecology has been developed. The transfer from the usage of luminescent dosimeters LiF:Mg,Ti with macro sizes (more than 1 mm) to microdosimetrs with sizes of about 0.1 mm, in combination with the developed protocols of dose estimations using mini-aliquots (10 mg) of luminescent microdosimeters, provided possibility to increase the accuracy of dose measurements in the therapeutic dose range at high dose rate brachytherapy of gynecological malignancies. The developed technology of intracavitary dosimetry at a high dose rate brachytherapy (¹²⁹Ir source) in oncogynecology was tested in the clinic (25 patients). It was found that, as a rule, the measured doses were in a good agreement with the calculated doses in the areas of interest. However, in four cases (16% of all patients) there was an excess of the measured local absorbed doses over the calculated ones (from 0.6 to 1 Gy) in the urethra and rectum (in the organs of maximum calculated doses). These cases may be considered as a basis for monitoring of the patients’ condition in the posttherapeutic period. However, the values of maximal dose were within acceptable dose range, as recommended by GEC-ESTRO. The developed technology of «in vivo» dosimetry allows to adjust the dosimetrical plans at multifractional high dose rate brachytherapy. The results of clinical approbation of the developed technology of «in vivo» dosimetry show the importance of this technology as an essential element of dosimetric assurance of the quality of high dose rate brachytherapy in oncogynecology.

Key words
«in vivo» dosimetry, luminescent microdosimeters, high dose rate brachytherapy, oncogynecology.

References

1. Ivanov S.A., Kaprin A.D., Milenin K.N., Albitsky I.A., Ivanenko K.V. Results of the use of low-dose brachytherapy as a radical treatment for prostate cancer. Diagnosticheskaya i interventsionnaya radiologiya – Diagnostic and Interventional Radiology, 2015, vol. 5, no. 1, pp. 73-76. (In Russian).

2. Kaprin A.D., Galkin V.N., Ivanov S.A. The role of brachytherapy in the treatment of localized forms of prostate cancer. Biomedical Photonics, 2015, vol. 4, no. 4, pp. 21-26. (In Russian).

3. Brachytherapy. Eds.: A.D. Kaprin, Yu.S. Mardynsky. Obninsk, A. Tsyb MRRC, 2017. 244 p. (In Russian).

4. Kutrevelis P. A new method of treatment of prostate cancer. Ed.: A.F. Tsyb. Moscow, Open Solution, 2007. 167 p. (In Russian).

5. Brachytherapy: applications and techniques. 2nd ed. Eds.: Ph.M. Devlin, R.A. Cormack, C.L. Holloway, A.J. Stewart. New York, Springer Publishing Company, 2015. 576 p.

6. Williamson J.F. Brachytherapy technology and physics practice since 1950: a half‐century of progress. Phys. Med. Biol., 2006, vol. 51, no. 13, pp. R303-R325.

7. Radiotherapy Risk Profile. WHO/IER/PSP/2008.12. Geneva, WHO, 2008. 51 p.

8. Van Dyk J., Barnett R.B., Cygler J.E., Shragge P.C. Commissioning and quality assurance of treatment planning computers Int. J. Radiat. Oncol. Biol. Phys., 1993, vol. 26, no. 2, pp. 261-273.

9. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Ivannikov A.I., Borysheva N.B., Skvortsov V.G., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Obukhov A.A., Anokhin Yu.N. Intracavitary offline "in vivo" dosimetry for high dose-rate prostate brachytherapy with 192Ir: development of technology and first results of its application. Radiatsia i Risk – Radiation and Risk, 2017, vol. 26, no. 2, pp. 72-82. (In Russian).

10. Development of procedures for in vivo dosimetry in radiotherapy. Human Health Reports No. 8. Vienna, IAEA, 2013. 179 p.

11. ICRP, 2005. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Ann. ICRP, 2005, vol. 35, no. 2, pp. 1-52.

12. ICRP, 2000. Prevention of accidental exposures to patients undergoing radiation therapy. ICRP Publication 86. Ann. ICRP, 2000, vol. 30, no. 3, pp. 7-70.

13. Potter R., Van Limbergen E., Gerstner N., Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother. Oncol., 2001, vol. 58, no. 1, pp. 11-18.

14. Allahverdi M., Sarkhosh M., Aghili M., Jaberi R., Adelnia A., Geraily G. Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered. Radiat. Prot. Dosim., 2012, vol. 150, no. 3, pp. 312-315.

15. Suchowerska N., Jackson M., Lambert J., Yin Y.B., Hruby G., McKenzie D.R. Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors. Int. J. Radiat. Oncol. Biol. Phys., 2011, vol. 79, no. 2, pp. 609-615.

16. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Borysheva N.B., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Obukhov A.A., Ivannikov A.I., Skvortsov V.G., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Anokhin Yu.N. In vivo dosimetry at high dose rate brachytherpapy for prostate cancer using 192Ir: comparison of dose distribution between planned and measured doses with intracavitary placement of autonomous luminescence microdosimeters. Radiatsia i risk – Radiation and Risk, 2018, vol. 27, no. 1, pp. 77-85. (In Russian).

17. Korotkov V.A., Biryukov V.A., Kaprin A.D., Ivanov S.A., Stepanenko V.F., Borysheva N.B., Obukhov, A.A., Kolyzhenkov T.V., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Zharova E.P. Manifestations of late radiation urethritis in comparison with instrumental assessments of the spatial intra-cavity distribution of doses in the organ after high dose rate brachytherapy of prostate cancer with the use of 192Ir: preliminary results. Radiatsia i risk – Radiation and Risk, 2019, vol. 28, no. 1, pp. 110-123. (In Russian).

18. Bogacheva V.V., Korotkov V.A., Biryukov V.A., Kaprin A.D., Ivanov S.A., Stepanenko V.F., Petukhov A.D., Kolyzhenkov T.V., Akhmedova U.A. Technology of intra-cavity "in vivo" dosimetry using autonomous fluorescent microdosimeters to measure the spatial distribution of the absorbed dose in patients during high-power brachytherapy of prostate cancer. Voprosy urologii i andrologii – Questions of Urology and Andrology, 2019, vol. 7, no. 2, pp. 39-40. (In Russian).

19. Titova V.A., Kokontsev D.A., Belle T.S. Clinical problems of direct dosimetry (in vivo) in contact radiation therapy. Biomedical Photonics, 2018, vol. 7, no. 2, pp. 19-24. (In Russian).

20. Sumin A.V., Medvedkov A.M., Vasiliev V.N., Smyslov A.Yu., Rusetskiy S.S., Kokontsev A.A., Titova V.A., Kokontsev D.A. Verification of the scintillation multichannel clinical dosimeter MKD-04 in a collimated 60Co gamma radiation beam. Meditsinskaya fizika – Medical Physics, 2017, vol. 75, no. 3, pp. 24-33. (In Russian).

Full-text article (in Russian)